<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>OptiBiotix Archives - UK Investor Magazine</title>
	<atom:link href="https://ukinvestormagazine.co.uk/tag/optibiotix/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestormagazine.co.uk/tag/optibiotix/</link>
	<description>UK Investor Magazine provides breaking financial news and investment ideas</description>
	<lastBuildDate>Wed, 21 Jan 2026 11:58:10 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.5</generator>

<image>
	<url>https://ukinvestormagazine.co.uk/wp-content/uploads/2025/05/cropped-favicon-96-96-32x32.jpg</url>
	<title>OptiBiotix Archives - UK Investor Magazine</title>
	<link>https://ukinvestormagazine.co.uk/tag/optibiotix/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>AIM movers: Goldstone Resources premium fundraising and Firering Strategic Minerals takes up option</title>
		<link>https://ukinvestormagazine.co.uk/aim-movers-goldstone-resources-premium-fundraising-and-firering-strategic-minerals-takes-up-option/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-movers-goldstone-resources-premium-fundraising-and-firering-strategic-minerals-takes-up-option/#comments</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Wed, 21 Jan 2026 11:58:09 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[EQTEC]]></category>
		<category><![CDATA[Firering Strategic Minerals]]></category>
		<category><![CDATA[Goldstone Resources]]></category>
		<category><![CDATA[Indus Gas]]></category>
		<category><![CDATA[OptiBiotix]]></category>
		<category><![CDATA[Oscillate]]></category>
		<category><![CDATA[Pulsar Helium Inc]]></category>
		<category><![CDATA[Shield Therapeutics]]></category>
		<category><![CDATA[Sovereign Metals]]></category>
		<category><![CDATA[Tan Delta Systems]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=85915</guid>

					<description><![CDATA[<img width="300" height="169" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2021/04/Goldstone-Resources-26421-300x169.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" fetchpriority="high" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2021/04/Goldstone-Resources-26421-300x169.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2021/04/Goldstone-Resources-26421-768x432.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2021/04/Goldstone-Resources-26421-150x84.jpg 150w, https://ukinvestormagazine.co.uk/wp-content/uploads/2021/04/Goldstone-Resources-26421-600x338.jpg 600w, https://ukinvestormagazine.co.uk/wp-content/uploads/2021/04/Goldstone-Resources-26421-696x392.jpg 696w, https://ukinvestormagazine.co.uk/wp-content/uploads/2021/04/Goldstone-Resources-26421-746x420.jpg 746w, https://ukinvestormagazine.co.uk/wp-content/uploads/2021/04/Goldstone-Resources-26421.jpg 1000w" sizes="(max-width: 300px) 100vw, 300px" /><p>Goldstone Resources (LON: GRL) is raising £2m at 1p/share, which was more than double the share price ahead of the announcement. The cash will fund exploration at the Homase mine in Ghana to expand the JORC resource and to evaluate other gold projects, including one in Sierra Leone. Asian Investment Management is converting £1.45m of [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-movers-goldstone-resources-premium-fundraising-and-firering-strategic-minerals-takes-up-option/">AIM movers: Goldstone Resources premium fundraising and Firering Strategic Minerals takes up option</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-movers-goldstone-resources-premium-fundraising-and-firering-strategic-minerals-takes-up-option/feed/</wfw:commentRss>
			<slash:comments>30</slash:comments>
		
		
			</item>
		<item>
		<title>AIM movers: Shell Earnz makes initial energy services acquisitions and Jarvis Securities well below expectations</title>
		<link>https://ukinvestormagazine.co.uk/aim-movers-shell-earnz-makes-initial-energy-services-acquisitions-and-jarvis-securities-well-below-expectations/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-movers-shell-earnz-makes-initial-energy-services-acquisitions-and-jarvis-securities-well-below-expectations/#respond</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Thu, 08 Aug 2024 10:28:17 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[Earnz]]></category>
		<category><![CDATA[FIH Group]]></category>
		<category><![CDATA[Hermes Pacific Investments]]></category>
		<category><![CDATA[Jarvis Securities]]></category>
		<category><![CDATA[Ocean Harvest Technology]]></category>
		<category><![CDATA[OptiBiotix]]></category>
		<category><![CDATA[Premier African Minerals]]></category>
		<category><![CDATA[SkinBioTherapeutics]]></category>
		<category><![CDATA[uk oil & gas]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=74657</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/Small-Mid-Cap-Roundup-Homeserve-Ferrexpo-XP-Factory-Vivo-Energy-22-4-22-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/Small-Mid-Cap-Roundup-Homeserve-Ferrexpo-XP-Factory-Vivo-Energy-22-4-22-300x200.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/Small-Mid-Cap-Roundup-Homeserve-Ferrexpo-XP-Factory-Vivo-Energy-22-4-22-768x512.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/Small-Mid-Cap-Roundup-Homeserve-Ferrexpo-XP-Factory-Vivo-Energy-22-4-22-150x100.jpg 150w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/Small-Mid-Cap-Roundup-Homeserve-Ferrexpo-XP-Factory-Vivo-Energy-22-4-22-600x400.jpg 600w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/Small-Mid-Cap-Roundup-Homeserve-Ferrexpo-XP-Factory-Vivo-Energy-22-4-22-696x464.jpg 696w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/Small-Mid-Cap-Roundup-Homeserve-Ferrexpo-XP-Factory-Vivo-Energy-22-4-22-630x420.jpg 630w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/Small-Mid-Cap-Roundup-Homeserve-Ferrexpo-XP-Factory-Vivo-Energy-22-4-22.jpg 1000w" sizes="(max-width: 300px) 100vw, 300px" /><p>UK Oil and Gas (LON: UKOG) has raised £248,000 in its retail offer at 0.05p/share, having already raised £1m in a placing. The cash fund further development of hydrogen storage products and permit negotiations with potential partners. The share price improved 15.6% to 0.063p. Full year results for FIH Group (LON: FIH) were in line [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-movers-shell-earnz-makes-initial-energy-services-acquisitions-and-jarvis-securities-well-below-expectations/">AIM movers: Shell Earnz makes initial energy services acquisitions and Jarvis Securities well below expectations</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-movers-shell-earnz-makes-initial-energy-services-acquisitions-and-jarvis-securities-well-below-expectations/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>OptiBiotix Health shares tumble as HY1 sales &#8220;materially lower&#8221; than expected</title>
		<link>https://ukinvestormagazine.co.uk/optibiotix-health-shares-tumble-as-hy1-sales-materially-lower-than-expected/</link>
					<comments>https://ukinvestormagazine.co.uk/optibiotix-health-shares-tumble-as-hy1-sales-materially-lower-than-expected/#respond</comments>
		
		<dc:creator><![CDATA[Natasha Doris]]></dc:creator>
		<pubDate>Wed, 24 Aug 2022 09:41:24 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[AIM]]></category>
		<category><![CDATA[Health science]]></category>
		<category><![CDATA[Investment]]></category>
		<category><![CDATA[London stocks]]></category>
		<category><![CDATA[OptiBiotix]]></category>
		<category><![CDATA[UK market]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=57794</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/08/OptiBiotix-24082022-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/08/OptiBiotix-24082022-300x200.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/08/OptiBiotix-24082022-768x513.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/08/OptiBiotix-24082022-150x100.jpg 150w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/08/OptiBiotix-24082022-600x401.jpg 600w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/08/OptiBiotix-24082022-696x465.jpg 696w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/08/OptiBiotix-24082022-629x420.jpg 629w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/08/OptiBiotix-24082022.jpg 1000w" sizes="(max-width: 300px) 100vw, 300px" /><p>OptiBiotix Health shares tumbled 27.4% to 19.7p in late morning trading on Wednesday after the group reported current sales in its new structure following its listing of ProBiotix on the AQSE to be &#8220;materially lower&#8221; than expected in HY1. The health sciences firm reported expected sales of £120,000, with sales normalising in HY2, but at [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/optibiotix-health-shares-tumble-as-hy1-sales-materially-lower-than-expected/">OptiBiotix Health shares tumble as HY1 sales &#8220;materially lower&#8221; than expected</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/optibiotix-health-shares-tumble-as-hy1-sales-materially-lower-than-expected/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>OptiBiotix revenues rise to £2.2m on Probiotics &#038; Prebiotics success</title>
		<link>https://ukinvestormagazine.co.uk/optibiotix-revenues-rise-to-2-2m-on-probiotics-prebiotics-success/</link>
					<comments>https://ukinvestormagazine.co.uk/optibiotix-revenues-rise-to-2-2m-on-probiotics-prebiotics-success/#respond</comments>
		
		<dc:creator><![CDATA[Natasha Doris]]></dc:creator>
		<pubDate>Tue, 28 Jun 2022 14:52:27 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[AIM]]></category>
		<category><![CDATA[Investment]]></category>
		<category><![CDATA[London stocks]]></category>
		<category><![CDATA[OptiBiotix]]></category>
		<category><![CDATA[Prebiotics]]></category>
		<category><![CDATA[Probiotics]]></category>
		<category><![CDATA[UK market]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=55234</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/06/Optibiotix-28062022-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/06/Optibiotix-28062022-300x200.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/06/Optibiotix-28062022-768x512.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/06/Optibiotix-28062022-150x100.jpg 150w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/06/Optibiotix-28062022-600x400.jpg 600w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/06/Optibiotix-28062022-696x464.jpg 696w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/06/Optibiotix-28062022-630x420.jpg 630w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/06/Optibiotix-28062022.jpg 1000w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>OptiBiotix shares were up 0.8% to 20.6p in late afternoon trading on Tuesday following a reported 45.3% rise in revenue to £2.2 million against £1.5 million in FY 2021. The firm announced a 27.7% increase in gross profit to £1.1 million from £879,000, alongside a climb in its Probiotic business sales of 34% to £1.1 [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/optibiotix-revenues-rise-to-2-2m-on-probiotics-prebiotics-success/">OptiBiotix revenues rise to £2.2m on Probiotics &#038; Prebiotics success</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/optibiotix-revenues-rise-to-2-2m-on-probiotics-prebiotics-success/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>OptiBiotix spinning off ProBiotix Health on Aquis</title>
		<link>https://ukinvestormagazine.co.uk/optibiotix-spinning-off-probiotix-health-on-aquis/</link>
					<comments>https://ukinvestormagazine.co.uk/optibiotix-spinning-off-probiotix-health-on-aquis/#comments</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Thu, 17 Mar 2022 22:31:00 +0000</pubDate>
				<category><![CDATA[AQUIS]]></category>
		<category><![CDATA[Premium]]></category>
		<category><![CDATA[Shares]]></category>
		<category><![CDATA[UK Investor Vantage]]></category>
		<category><![CDATA[LON: SBTX]]></category>
		<category><![CDATA[LON:OPTI]]></category>
		<category><![CDATA[OptiBiotix]]></category>
		<category><![CDATA[ProBiotix]]></category>
		<category><![CDATA[SkinBioTherapeutics]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=47929</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2019/08/NMC-Healthcare-deal-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2019/08/NMC-Healthcare-deal-300x200.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/08/NMC-Healthcare-deal-768x512.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/08/NMC-Healthcare-deal-630x420.jpg 630w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/08/NMC-Healthcare-deal-537x360.jpg 537w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/08/NMC-Healthcare-deal-640x427.jpg 640w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/08/NMC-Healthcare-deal-681x454.jpg 681w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/08/NMC-Healthcare-deal.jpg 1000w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>OptiBiotix Health (LON: OPTI) plans to spin off its ProBiotix Health subsidiary on the Aquis Stock Exchange. ProBiotix develops probiotics for treating cardiovascular disease and is expected to join the market on 31 March. OptiBiotix will retain a stake and transfer other ProBiotix shares to its own shareholders. &#160; Peterhouse will be the corporate adviser. [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/optibiotix-spinning-off-probiotix-health-on-aquis/">OptiBiotix spinning off ProBiotix Health on Aquis</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/optibiotix-spinning-off-probiotix-health-on-aquis/feed/</wfw:commentRss>
			<slash:comments>2</slash:comments>
		
		
			</item>
		<item>
		<title>OptiBiotix sign licensing deal with Granja Pocha SA in Uruguay</title>
		<link>https://ukinvestormagazine.co.uk/optibiotix-sign-licensing-deal-with-granja-pocha-sa-in-uruguay/</link>
					<comments>https://ukinvestormagazine.co.uk/optibiotix-sign-licensing-deal-with-granja-pocha-sa-in-uruguay/#respond</comments>
		
		<dc:creator><![CDATA[Ishen Patel]]></dc:creator>
		<pubDate>Wed, 12 Feb 2020 13:16:45 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[OptiBiotix]]></category>
		<category><![CDATA[probiotic]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=27027</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2020/02/shutterstock_1036394278-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2020/02/shutterstock_1036394278-300x200.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/02/shutterstock_1036394278-768x512.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/02/shutterstock_1036394278-630x420.jpg 630w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/02/shutterstock_1036394278-537x360.jpg 537w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/02/shutterstock_1036394278-640x427.jpg 640w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/02/shutterstock_1036394278-681x454.jpg 681w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/02/shutterstock_1036394278.jpg 1000w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>OptiBiotix (LON:OPTI) have told shareholders that they have signed a licensing deal with Granja Pocha SA on Wednesday. The firm said that the deal will allow the the LPLDL probiotic added to a yoghurt project in Uruguay. The probiotic strain is a development product from OptiBiotix, and has uses to reduce cholesterol and blood pressure. [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/optibiotix-sign-licensing-deal-with-granja-pocha-sa-in-uruguay/">OptiBiotix sign licensing deal with Granja Pocha SA in Uruguay</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/optibiotix-sign-licensing-deal-with-granja-pocha-sa-in-uruguay/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
